Known targets — ChEMBL curated mechanism
ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3CHRM1CHRM2CHRM3CHRM4ESR1ESR2GABRA1GABRB1GABRG2GBA1HRH1HTR1DHTR2AOPRD1OPRK1OPRM1SLC6A2SLC6A3TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Cadaverine Tartrate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 known ✓ | P04062 | 1/20 | 0.47 |
| ▸ | GABRA1 known ✓ | P14867 | 1/20 | 0.39 |
| ▸ | GABRB1 known ✓ | P18505 | 1/20 | 0.39 |
| ▸ | GABRG2 known ✓ | P18507 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 5/20 | 0.67 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.39 |
| ▸ | GABRP | O00591 | 1/20 | 0.39 |
| ▸ | GABRD | O14764 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.39 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.39 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.39 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.39 |
| ▸ | GABRE | P78334 | 1/20 | 0.39 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.39 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.39 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cadaverine Tartrate SCHEMBL5874937 | 0.97 | TSHR (0.62) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Cadaverine Tartrate SCHEMBL1642932 | 0.97 | TSHR (0.62) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Cadaverine Tartrate SCHEMBL27672363 | 0.91 | TSHR (0.56) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Cadaverine Tartrate SCHEMBL31315681 | 0.91 | TSHR (0.56) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Cadaverine Tartrate SCHEMBL2786076 | 0.91 | TSHR (0.56) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Tartaric Acid SCHEMBL29930272 | 0.89 | TSHR (0.53) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Cadaverine Tartrate SCHEMBL29643329 | 0.89 | TSHR (0.53) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Cadaverine Tartrate SCHEMBL5874109 | 0.89 | TSHR (0.53) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Cadaverine Tartrate SCHEMBL5874100 | 0.89 | TSHR (0.53) | TSHRGBA1NFKB1CYP2C19PMP22 | |
| Tartaric Acid SCHEMBL30597927 | 0.89 | TSHR (0.53) | TSHRGBA1NFKB1CYP2C19PMP22 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998042355-A1 | PHOSPHATE-BINDING POLYMERS COMBINED WITH A CALCIUM SUPPLEMENT FOR ORAL ADMINISTRATION | GELTEX PHARMACEUTICALS, INC. (US) | 1998-10-01 | — | — | WO | disclosed |
| WO-1996021454-A1 | PHOSPHATE-BINDING POLYMERS FOR ORAL ADMINISTRATION | GELTEX PHARMACEUTICALS, INC. (US) | 1996-07-18 | — | — | WO | disclosed |